Arrowstreet Capital, Limited Partnership Dbv Technologies S.A. Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.71 - $5.92 $243,978 - $306,656	-51,800 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.32 - $6.53 $11,299 - $13,869	2,124 Added 4.28%	51,800 $283,000
Q1 2021 May 14, 2021	SELL	$2.75 - $6.57 $4,741 - $11,326	-1,724 Reduced 3.35%	49,676 $265,000
Q4 2020 Feb 12, 2021	BUY	$1.38 - $3.01 $70,932 - $154,714	51,400 New	51,400 $135,000

37.7M

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $175M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.